Cumming D C, Cumming C E
Department of Obstetrics and Gynaecology, University of Alberta, Royal Alexandra Hospital, Edmonton, Alberta, Canada.
Sports Med. 2001;31(15):1025-31. doi: 10.2165/00007256-200131150-00001.
Physicians commonly recommend estrogen replacement as treatment for exercise-associated amenorrhoea. While the evidence shows that the basis of the amenorrhoea is estrogen deficiency, it is not clear that it is the only factor in the development of lowered bone density found in oligo-amenorrhoeic female athletes. Nutritional factors, significant in the development of the reproductive dysfunction, could also contribute to bone loss. No randomised, controlled studies of estrogen replacement in athletes have been published. However, one nonrandomised study of a small group of athletes does suggest that there are significant gains in bone density to be made by the initiation of estrogen therapy. More research is clearly needed.
医生通常推荐使用雌激素替代疗法来治疗运动性闭经。虽然有证据表明闭经的基础是雌激素缺乏,但尚不清楚这是否是少经女性运动员骨密度降低的唯一因素。在生殖功能障碍发展过程中起重要作用的营养因素,也可能导致骨质流失。目前尚未发表关于运动员雌激素替代疗法的随机对照研究。然而,一项针对一小群运动员的非随机研究确实表明,开始雌激素治疗可显著提高骨密度。显然还需要更多的研究。